Fluorouracil Catabolism in the Combination Treatment of Cyclophosphamide, Methotrexate and Fluorouracil

The CMF‐regimen is amongst the most effective chemotherapeutic approaches in the treatment of breast cancer. It is generally accepted that the efficacy of the combination of the three agents used in the regimen, i.e., cyclophosphamide (CY), methotrexate (MTX) and fluorouracil (FUra), is based on int...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Jpn J Cancer Res
Main Authors: De Bruijn, Ernst A., Van Der Heyden, Synke A. M., Gheuens, Eric E. O., Maes, Robert A. A.
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 1992
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918667/
https://ncbi.nlm.nih.gov/pubmed/1452462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1992.tb02728.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki